EnsoData Earns American Academy of Sleep Medicine Autoscoring Software Certification™ for EnsoSleep
EnsoSleep Artificial Intelligence (AI)-Powered Scoring Solution Recognized for Performance and Accuracy
MADISON, WI – May 7, 2024 – EnsoData, a pioneer in healthcare AI, is pleased to announce that its FDA-cleared diagnostic AI analysis and sleep scoring solution, EnsoSleep, earned stage-specific autoscoring software certification from the American Academy of Sleep Medicine (AASM).
According to the AASM, the AASM Autoscoring Certification program is “designed to rigorously assess and certify autoscoring software systems that analyze adult sleep stages via in-lab polysomnograms, ensuring they meet the AASM’s high standards for accuracy and reliability.”
EnsoSleep uses AI and machine learning (ML) to analyze data from sleep studies to aid physicians in diagnosing sleep disorders. Organizations utilizing EnsoSleep experience significant time savings – on average 62% for PSGs and 68% for HSATs. This opens up avenues for growth, provides opportunities to introduce new devices and programs, and boosts overall efficiency.
“We extend appreciation to the AASM for recognizing the high quality of EnsoData’s AI scoring software, acknowledging advancements in sleep medicine technology, and providing clinicians with confidence in the accuracy of AI scoring tools to assist in diagnosing sleep disorders” said Sam Rusk, EnsoData Chief AI Officer, “EnsoData is committed to connecting the patient journey from diagnostics to therapy and this certification marks one more step toward achieving this goal.”
The landscape of modern sleep disorder centers is evolving, with a shift in the execution of daily operations. Thanks to advancements in artificial intelligence technology, highly precise autoscoring solutions are emerging as essential components in sleep facilities of tomorrow.
About EnsoData:
EnsoData is a healthcare technology company that uses artificial intelligence (AI) and machine learning (ML) technology to perform complex and time-consuming data interpretation and analysis to help diagnose and treat health conditions.
Initially cleared by the FDA in 2017 and expanded in 2021, EnsoData’s sleep scoring and study management solution, EnsoSleep, uses AI to analyze the waveforms recorded by in-lab polysomnography (PSG) and home sleep apnea testing (HSATs). With the new clearance of EnsoSleep PPG, EnsoData adds the ability to AI score data provided by FDA-cleared pulse oximeters. EnsoSleep Study Management produces an annotated, scored, and editable sleep study report physicians and other clinicians use to make faster, more accurate diagnoses of sleep disorders. EnsoData has supported more than 1,300,000 patients across leading providers and health systems, including CommonSpirit Health, Rush University, Advanced Sleep Management, Sanford Health, Jiva Health, and UCHealth, resulting in more time for clinicians to expand patient care and improve patient outcomes.
